Vinblastine
Back to searchMolecule Structure
Scientific Name
Vinblastine
Description of the Drug
Vinblastine is a vinca alkaloid used to treat breast cancer, testicular cancer, neuroblastoma, Hodgkin’s and non-Hodgkins lymphoma, mycosis fungoides, histiocytosis, and Kaposi’s sarcoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00570
http://www.drugbank.ca/drugs/DB00570
Brand Name(s)
Not Available
Company Owner(s)
Fresenius Kabi Usa Llc, Hospira Inc, Abraxis Pharmaceutical Products, Eli Lilly And Co, Hikma Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Tubulin | PROTEIN COMPLEX GROUP | INHIBITOR | CHEMBL2095182 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL3628 | ||||
| DrugBank | DB00570 | ||||
| PubChem: Thomson Pharma | 15945566 | 16702846 | |||
| PubChem | 13342 | ||||
| Mcule | MCULE-9967454324 | ||||
| NMRShiftDB | 60029538 | ||||
| LINCS | LSM-6068 | ||||
| Nikkaji | J1.596.263A | J2.533.893F | |||
| PDBe | VLB | ||||
| BindingDB | 50012278 | ||||
| EPA CompTox Dashboard | DTXSID8021430 | ||||
| DrugCentral | 2823 | ||||
| Brenda | 230202 | 38815 | 6745 | 230203 | 32422 |
| Guide to Pharmacology | 6851 | ||||
| rxnorm | VINBLASTINE | VINBLASTINE SULFATE | |||
| ZINC | ZINC000085432544 |
